Back to search
FDAFDA · Food and drugs·Recall number D-0302-2015

BELVIQ® (Lorcaserin HCl) Tablets, 10 mg, 60-count bottle, Rx only, Manufactured by: Arena Pharmaceuticals, GmbH, Zofingen, Switzerland, Distributed by: Elsai Inc., Woodcliff, NJ 07677 NDC 62856-52960.

Published December 24, 2014 · Recall initiated: December 5, 2014

Summary

FDA records drug Class III recall D-0302-2015, published December 24, 2014 and initiated December 5, 2014. Recalling firm: Eisai Inc; Status: Terminated; Reported quantity: 121,680 bottles; Lot: Lot #13297008, Exp. 11/15;13307008, Exp. 11/15;13367008, Exp.12/15. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling:Missing Label: Bottles may not have a product label, or have a label with missing or illegible lot number and/or expiry date.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Eisai Inc
Distributor
Nationwide.
Lot
Lot #13297008, Exp. 11/15;13307008, Exp. 11/15;13367008, Exp.12/15.
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was BELVIQ® (Lorcaserin HCl) Tablets, 10 mg, 60-count bottle, Rx only, Manufactured by: Arena Pharmaceuticals, GmbH, Zofingen, Switzerland, Distributed by: Elsai Inc., Woodcliff, NJ 07677 NDC 62856-52960. recalled?

Yes. FDA published recall D-0302-2015 on December 24, 2014. Reported hazard: Labeling:Missing Label: Bottles may not have a product label, or have a label with missing or illegible lot number and/or expiry date.

What should I do if I have this product?

Voluntary: Firm initiated · Letter